Shaking, chills, and rigors with once-daily gentamicin

Area of Science:

• Pharmacology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Gentamicin is a widely used antibiotic for treating serious bacterial infections.
• Adverse drug reactions (ADRs) associated with gentamicin can impact patient safety and treatment outcomes.
• Understanding the mechanisms behind ADRs is crucial for optimizing antibiotic therapy.

Observation:

• A patient receiving once-daily gentamicin developed symptoms including shaking, chills, and rigors.
• Similar adverse events have been reported nationally across various healthcare institutions.
• These reactions suggest a potential issue with the gentamicin product or patient susceptibility.

Findings:

• The observed adverse reactions (shaking, chills, rigors) in patients receiving gentamicin are significant.
• While elevated endotoxin levels in a specific product are a suspected cause, this etiology requires further validation.
• Alternative or contributing factors to these gentamicin-induced adverse events must be investigated.

Implications:

• This highlights the importance of pharmacovigilance for gentamicin therapy.
• Investigating the precise cause of these reactions is critical for patient safety.
• Potential product quality issues or patient-specific factors warrant further research to prevent future occurrences.